Current Progress of Platelet-Rich Derivatives in Cartilage and Joint Repairs
August 2023
in “
International Journal of Molecular Sciences
”
Studysummary This review discusses the use of platelet-rich fibrin (PRF) in musculoskeletal, oral, and maxillofacial surgeries and dermatology, but reports no new clinical results; further trials are needed.
Our plain-language summary. Not medical advice or a treatment recommendation. Consult a qualified healthcare professional before changing treatment. Full disclaimer
The document reviews the use of platelet-rich derivatives, particularly platelet-rich fibrin (PRF), in cartilage and joint repairs. PRF is a second-generation platelet concentrate that promotes tissue regeneration through its fibrin matrix enriched with platelets and growth factors. It is highlighted for its simplified preparation, safety, and cost-effectiveness compared to platelet-rich plasma (PRP). PRF has shown promise in enhancing cartilage repair, stimulating chondrocyte viability, and providing a bioactive scaffold for regeneration. Despite its advantages, there is variability in treatment outcomes, and further research is needed to optimize its clinical applications. The document also notes the need for standardized preparation protocols due to inconsistencies in clinical results and emphasizes the potential of PRF in musculoskeletal and maxillofacial applications.
